To assess whether sGC stimulation can be used to induce weight loss in a clinically more relevant setting, that is, already established obesity, mice were fed a HFD for 12 weeks to induce DIO, followed by treatment of HFD with BAY for additional 6 weeks (Fig. 4d). The gene discussed is SGCB; the disease is obesity due to melanocortin 4 receptor deficiency.